I am somewhat confused regarding the safety of this vaccine, especially the threat of Guillain-Barré syndrome (GBS). For example my internist at first said not to take it but yesterday at my annual physical check, he said he changed his mind after reading more recent info. He was going to get it the next day. Also, that RSV infections has picked up in our area recently and he’s observed how nasty this infection is.
I would appreciate hearing what your decisions are and any experience to date.
Written by
podsart
To view profiles and participate in discussions please or .
AREXVY is the first FDA-approved vaccine used to prevent lung and lower airway infection from respiratory syncytial virus(RSV) in people 60 years and older.
Risk of RSV is MUCH higher than the GBS risk which is rare with or without the vaccine (two cases total so far). I got the vaccine and am happy I did.
"The FDA noted (PDF) that non-fatal serious adverse events were balanced between the placebo group and vaccine recipients at 2.3%, even with the instances of GBS. There were two total cases of GBS including the Miller Fisher syndrome event in 19,942 people who were vaccinated. The normal rate of GBS is about 1.5 to three cases per 100,000, according to the FDA."
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.